RASICA
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99100351
- Mark type
- Word mark
- Filed
- 24 Mar 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Michael K. Kinney
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical product evaluation; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer
Owner
- Hangzhou Adlai Nortye Biopharma Co., Ltd., Hangzhou, CN
- Hangzhou Adlai Nortye Biopharma Co., Ltd., Hangzhou, CN
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Aug 2025 — ASSIGNED TO EXAMINER
- 11 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Mar 2025 — NEW APPLICATION ENTERED